APPLICATION
NDA208424
TYPE
NDA
ORIGINAL APPROVAL
2016-06-08
LATEST ACTION
2016-06-08
ROUTE
SUBLINGUAL
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued
Products
GONITRO · ReferenceDiscontinued
NITROGLYCERIN 0.4MG/PACKET · POWDER · SUBLINGUAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.